Basic Information
Tantu Therapeutics is developing innovative microbiome-based targeted therapeutic protein fibers that are locally expressed and delivered at sites of intestinal lesions to treat IBD and other gastrointestinal (GI) diseases without systemic side effects.
Tantu Therapeutics, Inc.
Boston,Massachusetts,United States of America
unclear
January 01, 2020
--
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios